Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot
Rheumatology International · 19.07.2025 · 45 (8)
DOI: 10.1007/s00296-025-05930-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology International, online erschienen am 19.07.2025. Verfasst von Cara E Currier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA. Hauptthemen laut MEDLINE: Giant Cell Arteritis, C-Reactive Protein, Inflammation Mediators. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA.
- Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, USA. alisonmb@uw.edu.
- Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, USA.
ORCID-Profile: A M Bays, J L Thomason
Zitieren
APA
Currier, C. E., Bays, A. M., & Thomason, J. L. (2025). Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot. Rheumatology International, 45(8). https://doi.org/10.1007/s00296-025-05930-3
Vancouver
Currier CE, Bays AM, Thomason JL. Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot. Rheumatology International. 2025;45(8). doi:10.1007/s00296-025-05930-3
BibTeX
@article{Currier2025,
author = {Currier, Cara E and Bays, A M and Thomason, J L},
title = {Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot},
journal = {Rheumatology International},
year = {2025},
volume = {45},
number = {8},
doi = {10.1007/s00296-025-05930-3}
}
EUVIMED